Friday, September 28, 2018 9:19:30 AM
WHAT IT IS:
A shelf offering is a sale of stock by a company over time.
HOW IT WORKS (EXAMPLE):
Let's say Company XYZ is a public company and would like to sell shares in order to raise money to build a new factory. The company already has some Series A common stock outstanding; this new offering would be of Series B common stock that carries a different dividend. Company XYZ wants to sell 1 million shares of the stock, but it doesn't need the money all at once, so it files a shelf offering with the SEC under Rule 415 of Regulation C of the Securities Act of 1933.
Company XYZ hires an investment bank to underwrite the offering, register it with the SEC and handle the sale. The company receives the proceeds from the sale of the shares.
Generally, a company can register a shelf offering up to three years in advance, meaning that it has that long to sell the shares. The company files a Form S-3, F-3, or F-6 to do this (the form depends on the type of security and the nature of the issuer). The issuer still has to file the quarterly, annual and other disclosures with the SEC even if it hasn't actually issued any securities under the shelf. If the three-year window is getting close to closing and the company hasn't sold all of the securities in the shelf registration, it can often file replacement registration statements to extend the offering.
Shelf offerings can be delayed offerings or continuous offerings. In a continuous offering, the company is agreeing to make shares available for sale immediately (though it might not actually sell any immediately, and that is the company's choice); in a delayed offering, the company does not intend to make any shares available for sale until later in the three-year window. The information contained in the shelf offering statement varies depending on whether the offering is delayed or continuous and whether the issuer is already public. Regardless, most of the time the prospectus describes the type of security offered, a summary of the issuer's business, the use of proceeds, and the plan of distribution. Sometimes the issuer will provide a prospectus supplement with more detail.
When the company actually issues shares registered under the shelf offering, we say the company is doing a "takedown."
WHY IT MATTERS:
Shelf offerings give the company the flexibility to get the paperwork out of the way now and then offer the shares only when it needs the cash or only when the market conditions are good. They also signal to investors that the company intends to raise capital for new projects, possible acquisitions, or maybe to refinance something. However, companies aren't the only entities that can do shelf offerings; they can also involve founders or other managers (such as venture capitalists) selling all or a portion of their stakes in a company. Shelf offerings thus give these shareholders a way to monetize their positions.
Shelf offerings can dilute existing shares considerably if the offering comes from the company because new shares are being created. Selling a large volume of shares all at once can exert downward pressure on the stock's price -- a situation that is exacerbated when the stock is already thinly traded.
All of my posts are my own thoughts/opinions and not a recommendation to buy or sell. As always do your own DD to guide your actions.
Recent XBIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:15:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:18:54 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:16:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 10:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/13/2023 10:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:30:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:42 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/18/2023 04:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 12:05:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:30:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM